Synthesis, Molecular Modelling and In Vitro Anti-inflammatory Activity of Novel 1,2,4-Triazolo[4,3-a]quinoxaline Derivatives


DOĞAN İ. S., KAHVECİ B., SARI S., Kolci K., Reis R., Sipahi H.

ChemistrySelect, cilt.7, sa.26, 2022 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7 Sayı: 26
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1002/slct.202200935
  • Dergi Adı: ChemistrySelect
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier
  • Anahtar Kelimeler: 1, 2, 4-Triazolo[4, 3-a]quinoxalines, Synthesis, Anti-inflammatory activity, Molecular Docking, Structure-activity relationships, ONE-POT SYNTHESIS, QUINOXALINE DERIVATIVES, DISCOVERY, FACILE, CYCLIZATION, INHIBITOR, DOCKING, DESIGN
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

© 2022 Wiley-VCH GmbH.In this study, a series of 12 new 1,2,4-triazolo[4,3-a]quinoxalines (3 a-l) were synthesized to investigate their anti-inflammatory activities. An efficient method for synthesis of 1,2,4-triazolo[4,3-a]quinoxaline compounds (3 a-l) rendered a cyclo-condensation between iminoester derivatives (Compounds 1 a-l) and 1-(quinoxalin-2-yl)hydrazine (Compound 2). The synthesized compound's structural elucidation was carried out using 1H- and 13C-NMR, Mass analysis. Cytotoxicity profiles of the title compounds were assessed by MTT assay, and anti-inflammatory activities were investigated by determining nitrite levels in LPS-induced RAW264.7 murine macrophage cells. In addition, the ability of the compounds to reduce nitrite levels was modelled using molecular docking method. Compound 3 a-l showed good anti-inflammatory activities. Compound 3 f exhibited the most remarkable nitrite-reducing effect (65.12±1.62 %), which was similar to the nitrite inhibition seen with IND (63.83±4.20 %) compared to LPS-induced control. Besides, 3 f was followed by 3 i and 3 g, causing a significant decline in nitrite levels (51.56±8.68 % and 51.13±8.29 %, respectively). Molecular docking studies predicted that the compounds showed high affinity and formed key interactions with the active site of inducible nitric oxide synthase (iNOS), a key enzyme responsible for elevated nitrite levels. Thus, the current study explored a new series of 1,2,4-triazolo[4,3-a]quinoxaline analogs with promising nitrite-reducing effects, most probably due to iNOS inhibition.